News: OraSure Technologies, Inc. (OSUR.O)

OSUR.O on Nasdaq

4.28USD
14 Dec 2009
Price Change (% chg)

$0.09 (+2.15%)
Prev Close
$4.19
Open
$4.20
Day's High
$4.29
Day's Low
$4.13
Volume
95,860
Avg. Vol
299,369
52-wk High
$4.55
52-wk Low
$2.16

view news for:
Select another date:

Tue, Dec 8 2009

U.S. Medicare to pay for HIV testing

* Medicare participants who seek screening also covered

Continue Reading

UPDATE 1-OraSure settles suit with Inverness, sees wider Q4 loss

* Says agreed to pay Inverness a sum of $3 mln in cash

U.S. Medicare may pay for HIV testing

WASHINGTON (Reuters) - Americans enrolled in the Medicare health insurance program would be able to get screened for HIV under a draft government proposal to pay for the tests.

U.S. Medicare may pay for HIV testing

WASHINGTON, Sept 9 (Reuters) - Americans enrolled in the Medicare health insurance program would be able to get screened for HIV under a draft government proposal to pay for the tests.

UPDATE 3-OraSure says FDA seeks more study on hepatitis C test

* Says to conduct additional testing, trial of HCV test

UPDATE 1-OraSure Technologies sees loss in Q2; shares plunge

May 6 (Reuters) - Diagnostic tests maker OraSure Technologies Inc posted a higher quarterly profit, but cut its outlook for the second quarter and full year citing inventory issues and legal expenses among reasons, sending its shares down 13 percent to their new year-low.

OraSure settles patent lawsuit with Schering-Plough

Nov 14 (Reuters) - Diagnostic tests maker OraSure Technologies Inc said it has agreed to settle its pending patent infringement litigation against Schering-Plough Healthcare Products Inc .

OraSure Technologies Inc Q3 results

ORASURE TECHNOLOGIES INC : * Forecasts fourth-quarter earnings per share $0.00 * Forecasts fiscal year earnings per share about $0.05 * Third-quarter revenue rose 21 percent to $21.4 million * Forecasts fourth-quarter revenue $19.5 million to $20 million * Forecasts fiscal year 2007 revenue about $83 million * Third-quarter earnings per share $0.00 * Reuters Estimates third-quarter earnings per share view $0.00, revenue view $21.21 million * Reuters Estimates fourth-quarter earning

OraSure says panel concludes Prestige Brands breached contract

Oct 23 (Reuters) - OraSure Technologies Inc said an arbitration panel concluded that the acquisition of a competing cryosurgical wart removal product by Prestige Brands Holdings Inc breached the distribution agreement with OraSure.

BlackRock cuts passive stake in OraSure, Valassis

Oct 10 (Reuters) - Asset manager BlackRock Inc filed with the U.S. Securities and Exchange Commission to disclose a cut in its passive ownership of OraSure Technologies Inc and Valassis Communications Inc .

Select another date:

Market Views

» More OSUR.O Market Views

Press Releases

view news for: